Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

DTIL holding history

Precision Biosciences Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DTIL overviewAll 13F holders of DTILFull Q2 2026 holdings

Shares (Q2 2026)
58,699
Value
$461.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DTIL by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202658,699$461.4K<0.1%−22,434−27.7%ReducedHolders
Q1 202681,133$446.2K<0.1%+19,801+32.3%AddedHolders
Q4 202561,332$255.1K<0.1%+36,856+150.6%AddedHolders
Q3 202524,476$135.1K<0.1%−27,130−52.6%ReducedHolders
Q2 202551,606$216.7K<0.1%−5,421−9.5%ReducedHolders
Q1 202557,027$272.0K<0.1%−11,588−16.9%ReducedHolders
Q4 202468,615$261.4K<0.1%+66,732+3,543.9%AddedHolders
Q3 20241,883$16.9K<0.1%+1,676+809.7%AddedHolders
Q2 2024207$2.01K<0.1%+1+0.5%AddedHolders
Q1 2024206$2.79K<0.1%−2,752−93.0%ReducedConverted for a 1-for-30 splitHolders
Q4 202388,736$32.4K<0.1%+8,988+11.3%AddedHolders
Q3 202379,748$27.2K<0.1%+14,921+23.0%AddedHolders
Q2 202364,827$34.1K<0.1%+61,678+1,958.7%AddedHolders
Q1 20233,149$2.37K<0.1%−15,162−82.8%ReducedHolders
Q4 202218,311$21.8K<0.1%+14,606+394.2%AddedHolders
Q3 20223,705$5.00K<0.1%+2,556+222.5%AddedHolders
Q2 20221,149$2.00K<0.1%00.0%UnchangedHolders
Q1 20221,149$4.00K<0.1%−142,860−99.2%ReducedHolders
Q4 2021144,009$1.07M<0.1%+57,601+66.7%AddedHolders
Q3 202186,408$997.0K<0.1%+69,116+399.7%AddedHolders
Q2 202117,292$217.0K<0.1%−312,879−94.8%ReducedHolders
Q1 2021330,171$3.42M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.